Until recently, a patient could not receive an Alzheimer’s diagnosis without an expensive scan or invasive procedure. Last year, the Food and Drug Administration (FDA) cleared two blood-based biomarker tests—or BBB—that require only a routine blood sample for use in diagnosing Alzheimer’s disease. This is an important step forward in Alzheimer’s care, but it won’t…
Watch live: Getting a Diagnosis ASAP: Progress in Early Alzheimer’s Detection
Originally reported by The Hill
Related Articles
Trump Gets Payback on Indiana Republicans: 5 Takeaways
The president helped unseat most of the state lawmakers he targeted after they rebuffed his call to draw new House maps ...
U.S. Military Strikes Boat in Eastern Pacific, Killing 3
The attack was the second in two days, and the latest in an ongoing campaign against people the United States says are e...
Mrvan, Regnitz set for November House matchup in Indiana
Democrat Rep. Frank Mrvan (Ind.) is set to face off this fall against Republican Porter County Commissioner Barb Regnitz...
Trump Posts Meme of Top Democrats in Sombreros
The fake image of Representative Hakeem Jeffries of New York and Senator Chuck Schumer of New York was similar to a post...